FindTrial
Sign In

Comparative Clinical Study of Erand mool siidha kshir basti and Ashwatha khseer basti in management of vatarakta i.e. Gouty artheritis

A COMPARATIVE CLINICAL STUDY OF ERANDA MOOLA SIDDHA KSHEERA BASTI AND ASHWATTHA SIDDHA KSHEERA BASTI IN VATARAKTA

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/03/032411
Enrollment
44
Registered
2021-03-30
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M258- Other specified joint disorders

Interventions

Intervention1: ERANDA MOOLA SIDDHA KSHEERA BASTI: DOSE - 240ML FREQUENCY - ALTERNATE DAY FOR 8 DAYS ROUTE OF ADMINISTRATION - ANAL ROUTE DURATION - 8 DAYS Control Intervention1: ASHWATTHA SIDDHA KSHEE

Sponsors

SANE GURUJI AROGYA KRNDRA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: BASTI ARHA PATIENTS HAVING SIGNS AND SYMPTOMS OF VATARAKTA AS MENTIONED BY CLASSICAL AYURVEDA TEXTS.

Exclusion criteria

Exclusion criteria: KNOWN CASE OF MAJOR ILLNESS SUCH AS TB, AIDS,CANCER OTHER SYSTEMIC DISEASES LIKE DISEASES OF NERVOUS SYSTEM H/O SEVERE INJURY, FRACTURES, DISLOCATIONS, TRAUMA

Design outcomes

Primary

MeasureTime frame
TO COMPARE THE EFFECT OF ERANDA MOOLA SIDDHA KSHEERA BASTI AND ASHWATTHA SIDDHA KSHEERA BASTI IN VATARAKTATimepoint: ASSESSMENT ON DAY 8 AND DAY 15—

Secondary

MeasureTime frame
TO ASSESS THE EFFECT OF ERANDA MOOLA SIDDHA KSHEERA BASTI IN VATARAKTA AS PER YOGA BASTI KRAMATimepoint: PATIENT WILL BE ASSESSED ON 1,3,8,15TH DAY.—

Countries

India

Contacts

Public ContactDR SUCHITA PRATAPRAO NIMBALKAR

SUMATIBHAI SHAH AYURVEDA MAHAVIDYALAY,MALWADI,HADAPSAR,PUNE

drvandanapalve@gmail.com9890608788

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026